Company intelligence / Profile preview

Digestiva

Davis, California, United Statesdigestiva.com ↗

Ownership: Private
Development stage: Other

Overview

Digestiva has developed a proprietary enzyme platform to enhance protein digestibility and nutritional value in food and dietary supplements. Their precision proteases have shown improved bioavailability of proteins in both plant and animal sources. Pilot human studies and industrial trials indicate potential for transforming the quality of protein ingredients, with initial commercialization efforts underway targeting human nutrition, animal feed, and pet food sectors.

Therapeutic areas: OtherGastroenterologyMetabolic DisordersNeurology
Modalities: EnzymeRecombinant proteinPrecision protease (Enzyme)
Industry: Food & Nutrition

Partnerships

Magdalena (manufacturing partner)

Beyond the preview

Go deeper on Digestiva.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Digestiva.

Explore the full profile